Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 91

1.

Digital demand. Executing an efficient hospital data center strategy.

Leonidas T Jr, Derse D.

Health Facil Manage. 2013 Feb;26(2):31-4. No abstract available.

PMID:
23488054
2.

Cell-to-cell transmission can overcome multiple donor and target cell barriers imposed on cell-free HIV.

Zhong P, Agosto LM, Ilinskaya A, Dorjbal B, Truong R, Derse D, Uchil PD, Heidecker G, Mothes W.

PLoS One. 2013;8(1):e53138. doi: 10.1371/journal.pone.0053138. Epub 2013 Jan 7.

3.

Cell-cell transmission allows human T-lymphotropic virus 1 to circumvent tetherin restriction.

Ilinskaya A, Derse D, Hill S, Princler G, Heidecker G.

Virology. 2013 Feb 5;436(1):201-9. doi: 10.1016/j.virol.2012.11.012. Epub 2012 Dec 20.

4.

A reporter system for replication-competent gammaretroviruses: the inGluc-MLV-DERSE assay.

Aloia AL, Duffy L, Pak V, Lee KE, Sanchez-Martinez S, Derse D, Heidecker G, Cornetta K, Rein A.

Gene Ther. 2013 Feb;20(2):169-76. doi: 10.1038/gt.2012.18. Epub 2012 Mar 8.

5.

The role of ITCH protein in human T-cell leukemia virus type 1 release.

Dorjbal B, Derse D, Lloyd P, Soheilian F, Nagashima K, Heidecker G.

J Biol Chem. 2011 Sep 9;286(36):31092-104. doi: 10.1074/jbc.M111.259945. Epub 2011 Jul 1.

6.

The role of amino-terminal sequences in cellular localization and antiviral activity of APOBEC3B.

Pak V, Heidecker G, Pathak VK, Derse D.

J Virol. 2011 Sep;85(17):8538-47. doi: 10.1128/JVI.02645-10. Epub 2011 Jun 29.

7.
9.

Opposing effects of a tyrosine-based sorting motif and a PDZ-binding motif regulate human T-lymphotropic virus type 1 envelope trafficking.

Ilinskaya A, Heidecker G, Derse D.

J Virol. 2010 Jul;84(14):6995-7004. doi: 10.1128/JVI.01853-09. Epub 2010 May 12.

10.

Quantitative comparison of HTLV-1 and HIV-1 cell-to-cell infection with new replication dependent vectors.

Mazurov D, Ilinskaya A, Heidecker G, Lloyd P, Derse D.

PLoS Pathog. 2010 Feb 26;6(2):e1000788. doi: 10.1371/journal.ppat.1000788.

11.

Assembly of the murine leukemia virus is directed towards sites of cell-cell contact.

Jin J, Sherer NM, Heidecker G, Derse D, Mothes W.

PLoS Biol. 2009 Jul;7(7):e1000163. doi: 10.1371/journal.pbio.1000163. Epub 2009 Jul 28.

12.

Guidelines for naming nonprimate APOBEC3 genes and proteins.

LaRue RS, Andrésdóttir V, Blanchard Y, Conticello SG, Derse D, Emerman M, Greene WC, Jónsson SR, Landau NR, Löchelt M, Malik HS, Malim MH, Münk C, O'Brien SJ, Pathak VK, Strebel K, Wain-Hobson S, Yu XF, Yuhki N, Harris RS.

J Virol. 2009 Jan;83(2):494-7. doi: 10.1128/JVI.01976-08. Epub 2008 Nov 5. No abstract available.

13.

Intersubunit disulfide isomerization controls membrane fusion of human T-cell leukemia virus Env.

Li K, Zhang S, Kronqvist M, Wallin M, Ekström M, Derse D, Garoff H.

J Virol. 2008 Jul;82(14):7135-43. doi: 10.1128/JVI.00448-08. Epub 2008 May 14.

14.

Interactions of murine APOBEC3 and human APOBEC3G with murine leukemia viruses.

Rulli SJ Jr, Mirro J, Hill SA, Lloyd P, Gorelick RJ, Coffin JM, Derse D, Rein A.

J Virol. 2008 Jul;82(13):6566-75. doi: 10.1128/JVI.01357-07. Epub 2008 Apr 30.

15.

The role of WWP1-Gag interaction and Gag ubiquitination in assembly and release of human T-cell leukemia virus type 1.

Heidecker G, Lloyd PA, Soheilian F, Nagashima K, Derse D.

J Virol. 2007 Sep;81(18):9769-77. Epub 2007 Jul 3.

16.

Human T-cell leukemia virus type 1 integration target sites in the human genome: comparison with those of other retroviruses.

Derse D, Crise B, Li Y, Princler G, Lum N, Stewart C, McGrath CF, Hughes SH, Munroe DJ, Wu X.

J Virol. 2007 Jun;81(12):6731-41. Epub 2007 Apr 4.

17.

Resistance of human T cell leukemia virus type 1 to APOBEC3G restriction is mediated by elements in nucleocapsid.

Derse D, Hill SA, Princler G, Lloyd P, Heidecker G.

Proc Natl Acad Sci U S A. 2007 Feb 20;104(8):2915-20. Epub 2007 Feb 13.

18.

Phenotypic and genotypic comparisons of human T-cell leukemia virus type 1 reverse transcriptases from infected T-cell lines and patient samples.

Mitchell MS, Bodine ET, Hill S, Princler G, Lloyd P, Mitsuya H, Matsuoka M, Derse D.

J Virol. 2007 May;81(9):4422-8. Epub 2007 Feb 7.

19.

The inner loop of tetraspanins CD82 and CD81 mediates interactions with human T cell lymphotrophic virus type 1 Gag protein.

Mazurov D, Heidecker G, Derse D.

J Biol Chem. 2007 Feb 9;282(6):3896-903. Epub 2006 Dec 13.

20.

Human T-cell leukemia virus type 1 Tax protein down-regulates pre-T-cell receptor alpha gene transcription in human immature thymocytes.

Wencker M, Sausse C, Derse D, Gazzolo L, Duc Dodon M.

J Virol. 2007 Jan;81(1):301-8. Epub 2006 Oct 18.

21.

Antiretroviral potential of human tripartite motif-5 and related proteins.

Zhang F, Hatziioannou T, Perez-Caballero D, Derse D, Bieniasz PD.

Virology. 2006 Sep 30;353(2):396-409. Epub 2006 Jul 10.

22.

Synthesis, processing, and composition of the virion-associated HTLV-1 reverse transcriptase.

Mitchell MS, Tözsér J, Princler G, Lloyd PA, Auth A, Derse D.

J Biol Chem. 2006 Feb 17;281(7):3964-71. Epub 2005 Dec 19.

23.

HTLV-1 Gag protein associates with CD82 tetraspanin microdomains at the plasma membrane.

Mazurov D, Heidecker G, Derse D.

Virology. 2006 Mar 1;346(1):194-204. Epub 2005 Dec 1.

24.

Infectious transmission and replication of human T-cell leukemia virus type 1.

Derse D, Heidecker G, Mitchell M, Hill S, Lloyd P, Princler G.

Front Biosci. 2004 Sep 1;9:2495-9. Review.

PMID:
15353302
25.

cis-Acting and trans-acting modulation of equine infectious anemia virus alternative RNA splicing.

Liao HJ, Baker CC, Princler GL, Derse D.

Virology. 2004 May 20;323(1):131-40.

26.

Late assembly motifs of human T-cell leukemia virus type 1 and their relative roles in particle release.

Heidecker G, Lloyd PA, Fox K, Nagashima K, Derse D.

J Virol. 2004 Jun;78(12):6636-48.

27.

HTLV-1-encoded p30II is a post-transcriptional negative regulator of viral replication.

Nicot C, Dundr M, Johnson JM, Fullen JR, Alonzo N, Fukumoto R, Princler GL, Derse D, Misteli T, Franchini G.

Nat Med. 2004 Feb;10(2):197-201. Epub 2004 Jan 18.

28.

Roles of viral and cellular proteins in the expression of alternatively spliced HTLV-1 pX mRNAs.

Princler GL, Julias JG, Hughes SH, Derse D.

Virology. 2003 Dec 5;317(1):136-45.

29.

Activation of interleukin-13 expression in T cells from HTLV-1-infected individuals and in chronically infected cell lines.

Chung HK, Young HA, Goon PK, Heidecker G, Princler GL, Shimozato O, Taylor GP, Bangham CR, Derse D.

Blood. 2003 Dec 1;102(12):4130-6. Epub 2003 Aug 14.

30.

Susceptibility of human T cell leukemia virus type I to nucleoside reverse transcriptase inhibitors.

Hill SA, Lloyd PA, McDonald S, Wykoff J, Derse D.

J Infect Dis. 2003 Aug 1;188(3):424-7. Epub 2003 Jul 10.

PMID:
12870124
31.

Virology. Forced entry--or does HTLV-I have the key?

Derse D, Heidecker G.

Science. 2003 Mar 14;299(5613):1670-1. No abstract available.

PMID:
12637723
33.
34.
36.
38.

HIV type 1 protease inhibitors fail to inhibit HTLV-I Gag processing in infected cells.

Pettit SC, Sanchez R, Smith T, Wehbie R, Derse D, Swanstrom R.

AIDS Res Hum Retroviruses. 1998 Jul 20;14(11):1007-14.

PMID:
9686647
39.
40.

Inhibition of acute-, latent-, and chronic-phase human immunodeficiency virus type 1 (HIV-1) replication by a bistriazoloacridone analog that selectively inhibits HIV-1 transcription.

Turpin JA, Buckheit RW Jr, Derse D, Hollingshead M, Williamson K, Palamone C, Osterling MC, Hill SA, Graham L, Schaeffer CA, Bu M, Huang M, Cholody WM, Michejda CJ, Rice WG.

Antimicrob Agents Chemother. 1998 Mar;42(3):487-94.

43.

Bovine immunodeficiency virus tat gene: cloning of two distinct cDNAs and identification, characterization, and immunolocalization of the tat gene products.

Fong SE, Greenwood JD, Williamson JC, Derse D, Pallansch LA, Copeland T, Rasmussen L, Mentzer A, Nagashima K, Tobin G, Gonda MA.

Virology. 1997 Jul 7;233(2):339-57.

45.

Examining the molecular genetics of HTLV-I with an infectious molecular clone of the virus and permissive cell culture systems.

Derse D, Mikovits J, Waters D, Brining S, Ruscetti F.

J Acquir Immune Defic Syndr Hum Retrovirol. 1996 May 1;12(1):1-5. Review.

PMID:
8624755
47.

Detection of human T-cell leukaemia virus 1 permissive cells using cell lines producing selectable recombinant virions.

Copeland KF, Haaksma AG, Derse D, Heeney JL.

J Virol Methods. 1994 Dec;50(1-3):219-25.

PMID:
7714045
48.
49.

Posttranscriptional effector domains in the Rev proteins of feline immunodeficiency virus and equine infectious anemia virus.

Mancuso VA, Hope TJ, Zhu L, Derse D, Phillips T, Parslow TG.

J Virol. 1994 Mar;68(3):1998-2001.

50.

Cytochemical analysis of human T cell leukaemia virus I LTR-regulated beta-galactosidase gene expression using a novel integrated cell system.

Copeland KF, Haaksma AG, Derse D, Goudsmit J, Heeney JL.

J Virol Methods. 1993 Dec 15;45(2):161-7.

PMID:
8113342

Supplemental Content

Support Center